Winter Conference

29th Annual Aspirus Heart & Vascular Winter Conference

Current Trends in Cardiovascular Disease Management

The Winter Conference is an annual education event offered by Aspirus Heart & Vascular. It is held at the Westwood Conference Center in Wausau. This educational event covers a wide variety of topics related to heart care and heart health. Topics are presented by experts from Aspirus and throughout the country. The event is free for Aspirus employees and affiliates.

Conference Details

  • Date: Friday, February 8, 2019
  • Time: 7:45 am-3:30 pm (Registration from 7-7:45)
  • Location: Westwood Conference Center
  • Address: 1800 Westwood Center Boulevard, Wausau, WI, 54401
  • Other details: Lunch is included

Westwood Conference Center is an accessible, barrier-free location. Please contact Aspirus Heart and Vascular at 715-847-2000, extension 55245 if you require any special accommodations.

Download the information on this page in a printable format

Intended Audience

This conference is intended for cardiologists, general internists, family practice physicians, nurse practitioners, physician assistants, pharmacists, registered nurses, exercise physiologists, rehabilitation professionals, trainees in medicine and other specialists interested in cardiovascular risk factors and treatment options.

Learning Objectives

At the completion of this activity, participants will be able to:

  1. Describe best practices for effective use of lipid-lowering statin therapy using current national guidelines.
  2. Review clinical data supporting the use of non-statin therapy for patients with high atherosclerotic cardiovascular disease risk.
  3. Review the current guideline recommendations for vascular disease screening.
  4. Discuss vascular disease outcomes from disease screening combined with patient education through the DARE to Care Program.
  5. Discuss guidance on the peri-operative management of patients receiving NOACs.
  6. Review non-FDA approved uses for NOACs as seen in practice and described in clinical literature.
  7. Review diagnostic work up for suspected pulmonary arterial hypertension.
  8. Identify current FDA approved pulmonary arterial hypertension therapies.
  9. Discuss how to assess a patient’s readiness to quit and motivational interviewing techniques to encourage behavioral changes for smoking cessation.
  10. Review current FDA approved pharmacotherapy to aid in smoking cessation.
  11. List indications and outcomes for atrial fibrillation hybrid surgical/catheter ablations.
  12. Identify risk factors associated with Takotsubo.
  13. Discuss the role of catecholamines in drug-induced Takotsubo.

Conference Agenda

7-7:45 am – Registration and Exhibits

7:45-8 am – Welcome
David K. Murdock, MD, MS, FACC, FACP, FSCAI
Cardiologist, Aspirus Cardiology, Wausau, Wisconsin

8-8:40 am – Update of the 2018 ACC/AHA Cholesterol Guidelines
Alan S. Brown, MD, FACC, FAHA, FNLA, FASPC
Director, Advocate Lutheran General Hospital, Park Ridge, Illinois

8:40-9:20 am – Discover the Undiscovered: Lessons Learned from Two Decades of Vascular Screening
John D. Martin, MD, MBA, FACS
Vascular Surgeon and President, Heart Health Foundation, Annapolis, Maryland

9:20-9:35 am – Questions and Answers

9:35-10:05 am – Break and Exhibits

10:05-10:45 am – Non-vitamin K dependent Oral Anticoagulants (NOACs)
Craig T. January, MD, PhD, FACC
Professor, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

10:45-11:25 am – Contemporary Management and Treatment of Pulmonary Hypertension
Mark T. Hoffmann, MD, FACC
Interventional Cardiologist, Aspirus Cardiology, Wausau, Wisconsin

Lyle D. Joyce, MD, PhD,
Cardiac Surgery Specialist, Froedtert Hospital and Medical College of Wisconsin, Milwaukee, Wisconsin

11:25-11:40 am – Questions and Answers

11:40 am-12:40 pm – Buffet Lunch and Exhibits

12:40-1:20 pm – Treating All Smokers: An Overview of Evidence-Based Treatments
Megan E. Piper, PhD
Associate Professor and Associate Director of Research, University of Wisconsin Center for Tobacco Research & Intervention, Madison, Wisconsin

1:20-2 pm – Hybrid Atrial Fibrillation Interventions: Proven Benefits of a Combined Surgical and Catheter Based Approach
John Johnkoski, MD
Cardiovascular and Thoracic Surgeon, Aspirus Heart & Lung, Wausau, Wisconsin

2-2:15 pm – Questions and Answers

2:15-2:40 pm – Break and Exhibits

2:40-3:20 pm – Takotsubo Syndrome: Something is Happening Here
David K. Murdock, MD, MS, FACC, FACP, FSCAI
Cardiologist, Aspirus Cardiology, Wausau, Wisconsin

3:20-3:30 pm Questions and Answers

Registration and Fees

Pre-registration is required and registration is limited to 200 attendees.

Register Online

There is no fee for providers and employees of Aspirus, Inc. and Aspirus-affiliated organizations.  There is a $50 fee for no shows and cancellations after 4:00 p.m., January 29, 2019.

Registration for all other attendees: Physicians - $150; Pharmacists/NPs/ PAs/Retired Physicians - $75; RNs/all other health care providers - $50. Non-Aspirus registrants: Visa, MasterCard, and Discover accepted. Refunds will not be granted.

Please call 715-847-2000, extension 55245 with questions or for assistance.

If paying by check, make payable to Aspirus Wausau Hospital and mail to:

Aspirus Wausau Hospital
ATTN: AHV/Sharon Thacker
333 Pine Ridge Blvd.
Wausau, WI 54401

Continuing Education

Statement of Accreditation

Aspirus Wausau Hospital is accredited by the Wisconsin Medical Society to provide continuing education for physicians.

AMA/PRA Designation Statement

Aspirus Wausau Hospital designates this live activity for a maximum of 5.50 AMA PRA Category 1 CreditsTM. Attendees should claim only the credit commensurate with the extent of their participation in the activity.

The American Nurses Credentialing Center (ANCC) includes CME credit as formally accredited/approved contact hours.

Participants must complete an evaluation/attestation in order to receive educational credits. 

Pharmacy Continuing Education Requirements

This activity is structured to meet knowledge-based educational needs. A knowledge-based activity acquires factual knowledge. Information in knowledge-based activities is based on evidence as accepted in the literature by the health care professions. Pharmacy continuing education (PCE) credit will be earned based on participation in this activity. Any individual who is more than 10 minutes late to an activity or leaves an activity early will not be granted PCE credit. This procedure will be strictly enforced, so please plan accordingly. 

Participants must fully participate in the activity and complete an online activity evaluation and posttest questions, if received by presenters, with a passing score of 70 percent or greater before February 22, 2019.
Online evaluations and posttests will not be available for completion and requests to process credit will not be accepted after this date. See the program instruction sheet distributed during the activity for the online activity link. Posttests will not be graded and credit will not be processed until the online evaluation and posttest has officially closed for response. Please allow MPA two weeks to grade posttests and process and upload credit to CPE Monitor after the evaluation and posttest has closed. NOTE: ACPE guidelines prohibit MPA from issuing credit more than 60 days after the activity for any reason; therefore, to avoid denial of credit, it is imperative that pharmacists and pharmacy technicians complete the online evaluation and posttest by the deadline indicated to allow sufficient time for processing. If all requirements are met, participants will receive pharmacy continuing education (PCE) credit through CPE Monitor, a national, collaborative effort by ACPE and the National Association of Boards of Pharmacy (NABP) to provide an electronic system for pharmacists and pharmacy technicians to track their completed PCE credits. MPA, as an ACPE-accredited provider, is required to report pharmacist and pharmacy technician PCE credit using this tracking system. Pharmacist and pharmacy technician participants must provide their NABP e-Profile identification number and date of birth (in MMDD format) when they complete activity evaluations. It will be the responsibility of the participant to provide the correct information. If this information is not correctly provided, NABP and ACPE prohibit MPA from issuing CPE credit. Online access to their inventory of completed credits will allow pharmacists and pharmacy technicians to easily monitor their compliance with CPE requirements and print statements of credit. Therefore, MPA will not provide printed statements of credit to pharmacists and pharmacy technicians. Partial credit will not be awarded. If you have yet to sign up for CPE Monitor, go to MyCPEMonitor.net.

ACPE Universal Activity Number 0112-9999-19-311-L01-P
5.5 contact hours; Knowledge-based
Initial Release Date: 02/08/2019; Expiration Date: 02/08/2020

Michigan Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Conference Directors

  • Benjamin J. Herdrich, MD; Vascular Surgeon, Surgical Associates
  • David K. Murdock, MD, MS, FACC, FACP, FSCAI; Cardiologist, Aspirus Cardiology

Disclosure

It is the policy of Aspirus Wausau Hospital that faculty and sponsors disclose real or apparent conflict of interest relating to the topics of the educational activity, and also disclose discussions of unlabeled/ unapproved uses of drugs or devices during their presentation(s). Detailed disclosure will be made in the conference handout materials.

For Exhibitors

Interested in being a Winter Conference Exhibitor? Register online. The cost to be an exhibitor for this event is $1,500. If you have any questions or need to make other payment arrangements, please email the event organizer.

Register as Exhibitor